Lumakras (sotorasib), first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C
The FDA has approved Lumakras (sotorasib) as the first treatment for adult…
Tagrisso (osimertinib) , First Adjuvant Therapy for Most Common Type of Lung Cancer
The U.S. Food and Drug Administration has approved Tagrisso (osimertinib) as…